Related Experiment Video
Updated: Oct 23, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Effect of aprindine on heart rate variability indices in patients with ischemic heart disease
B Takase1, A Uehata, T Nishioka
1Self Defense Force Central Hospital, Internal Medicine, Tokyo, Japan.
Insights
Aprindine may improve heart rate variability (HRV) in patients with ischemic heart disease (IHD), particularly those with milder conditions. This antiarrhythmic agent does not worsen HRV, offering a potential treatment option for IHD patients with arrhythmias.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Decreased heart rate variability (HRV) is linked to adverse outcomes in ischemic heart disease (IHD).
- Most Class I antiarrhythmic drugs reduce HRV, but aprindine shows potential to increase it.
Purpose of the Study:
- To investigate the effect of aprindine on HRV in patients with IHD.
- To determine if aprindine can increase HRV in IHD patients.
Main Methods:
- 38 IHD patients with premature ventricular contractions (PVCs) underwent 24-h ambulatory ECG monitoring.
- A single-blind, 4-week, placebo-controlled study assessed HRV indices (SDNN, SDANN, SD, rMSSD, pNN50) and frequency analysis (total, low, high components) during placebo and aprindine (60 mg daily) phases.
Main Results:
- Aprindine increased rMSSD, pNN50, and high-frequency spectra in patients with mild IHD (Group 1).
- In patients with more severe IHD or no PVC reduction (Group 3), HRV indices generally decreased.
- No significant HRV changes were observed in patients with moderate IHD (Group 2).
Conclusions:
- Aprindine augments vagal activity in mild IHD, improving HRV.
- Aprindine does not aggravate HRV in IHD patients and may offer salutary effects on arrhythmias without proarrhythmic concerns.
Background:
Decreased heart rate variability indices (HRV) are associated with untoward outcome of patients with ischemic heart disease (IHD). Most class I antiarrhythmic agents decrease HRV, but aprindine (a new class I antiarrhythmic agent) is reported to increase HRV in patients without ischemia.
Hypothesis:
The study was undertaken to determine whether apridine might increase HRV in patients with IHD.
Methods:
To investigate the effect of aprindine on HRV in patients with IHD, we performed 24-h ambulatory electrocardiogram (ECG) at the end of placebo and aprindine (60 mg daily) treatment phases on 38 patients with IHD and at least isolated premature ventricular contractions (PVC). The study protocol utilized a single blind, 4-week, placebo-controlled design. Heart rate variability from ambulatory ECG included SDNN (ms), SDANN (ms), SD (ms), rMSSD (ms), pNN50 (%); frequency analysis of HRV consisting of total (ms, 0.01-1.00 Hz), low (ms, 0.04-0.15 Hz), and high (ms, 0.15-0.40 Hz) components.
Results:
Study patients were divided into three groups according to the severity of IHD and antiarrhythmic efficacy of aprindine. Group 1 consisted of 15 patients with angina with single-vessel disease, and Group 2 was composed of 10 patients with either multivessel disease or post myocardial infarction; PVCs decreased in both groups as result of aprindine treatment. Group 3 consisted of 13 patients who showed no decreased PVC after aprindine treatment. RMSSD increased, and pNN50 and high-frequency spectra tended to increase in Group 1, while SD, rMSSD, pNN50, and total and low-frequency spectra decreased in Group 3; no significant changes were observed in Group 2. Aprindine significantly augments vagal activity, as reflected by the increase of rMSSD, pNN50, and high-frequency spectra in mild IHD.
Conclusion:
These salutary effects are less in more severe IHD, but aprindine does not aggravate HRV. Thus, if there are salutary effects on arrhythmias and no proarrhythmic effects, aprindine could be prescribed to patients with IHD without concern about decreasing HRV.
More Related Videos
Related Concept Videos
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Factors Influencing Heart Rate
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias IV: Characteristics of Bradyarrhythmias

